ライフサイエンスコーパス: Staphylococcus

1 3 CD8 significantly correlated with OTU1348 (Staphylococcus).

2 Staphylococcus hyicus and Staphylococcus agnetis are two coagulase-variable staphy

3 aracterized by increases in the abundance of Staphylococcus and/or Streptococcus.

4 ts with patients with necrotizing fasciitis, Staphylococcus aureus (10 [43.5%] vs 4 [12.9%]; P = .02)

5 Aspergillus spp. (17%) and Staphylococcus aureus (10.7%) were the commonest pathoge

6 Staphylococcus aureus (12.9%) and Pseudomonas aeruginosa

7 cocci (21%, 10/48) and methicillin-sensitive Staphylococcus aureus (19%, 9/48).

8 positive bacterial pathogens was (88%), and Staphylococcus aureus (50.3%) was the predominantly isol

9 Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are the cause of a sever

10 Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) causes infections associ

11 e community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) epidemic in the United S

12 t, community-acquired, methicillin-resistant Staphylococcus aureus (CA-MRSA) with specific molecular

13 terococcus faecalis, Pseudomonas aeruginosa, Staphylococcus aureus (including clinical isolates of MR

14 Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) is an emerging problem i

15 control practices for methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Aci

16 erminal peptide of the methicillin-resistant staphylococcus aureus (MRSA) and self-assembles to form

17 luding the "superbugs" methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant En

18 iotic activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant En

19 zed projects involving methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant en

20 the treatment of both methicillin resistant Staphylococcus aureus (MRSA) and vancomycin-resistant st

21 ere is limited data on methicillin-resistant Staphylococcus aureus (MRSA) carriage in dental clinics.

22 Methicillin-resistant Staphylococcus aureus (MRSA) caused 57% of the ISIs.

23 was targeted to reduce methicillin-resistant Staphylococcus aureus (MRSA) growth.

24 e rate of infection by methicillin-resistant Staphylococcus aureus (MRSA) has declined over the past

25 e community-associated methicillin-resistant Staphylococcus aureus (MRSA) incidence in the United Sta

26 Methicillin-resistant Staphylococcus aureus (MRSA) infection is a serious thre

27 The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection was 24% and multi

28 Health care-associated methicillin-resistant Staphylococcus aureus (MRSA) infections are a burden on

29 talizations related to methicillin-resistant Staphylococcus aureus (MRSA) infections between 2010 and

30 ch to the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections by demonstrating

31 Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium that causes

32 Methicillin-resistant Staphylococcus aureus (MRSA) is an emerging cause of cat

33 Methicillin-resistant Staphylococcus aureus (MRSA) is responsible for large nu

34 Methicillin-resistant Staphylococcus aureus (MRSA) is the most common healthca

35 f community-associated methicillin-resistant Staphylococcus aureus (MRSA) is unclear.

36 ital and identified 81 methicillin-resistant Staphylococcus aureus (MRSA) isolates.

37 g epidemic lineages of methicillin-resistant Staphylococcus aureus (MRSA) over sensitive isolates (me

38 Methicillin-resistant Staphylococcus aureus (MRSA) represents a major contribu

39 at increased risk for methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infect

40 ts score, preoperative methicillin-resistant Staphylococcus aureus (MRSA) status, and receipt of mupi

41 Methicillin-resistant Staphylococcus aureus (MRSA) was first observed in 1960,

42 Meticillin-resistant Staphylococcus aureus (MRSA) was first reported in 1998

43 ococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA), Listeria monocytogenes and

44 with the emergence of methicillin-resistant Staphylococcus aureus (MRSA).

45 cal bacteria including methicillin-resistant Staphylococcus aureus (MRSA).

46 and drug resistance in methicillin-resistant Staphylococcus aureus (MRSA).

47 ng to the phenotype of methicillin-resistant Staphylococcus aureus (MRSA).

48 ng domains specific to methicillin-resistant Staphylococcus aureus (MRSA).

49 iotic activity against methicillin-resistant Staphylococcus aureus (MRSA).

50 treat patients with methicillin-susceptible Staphylococcus aureus (MSSA) infections, beta-lactams ar

51 ive bacteria, namely methicillin-susceptible Staphylococcus aureus (MSSA), methicillin-resistant Stap

52 ignificantly higher in methicillin-resistant Staphylococcus aureus (OR, 2.80; 95% CI, 1.65-4.74) and

53 ome of house dust mites (HDM) has shown that Staphylococcus aureus (S. aureus) and Escherichia coli (

54 that MCL played an anti-inflammatory role in Staphylococcus aureus (S. aureus) and methicillin-resist

55 Staphylococcus aureus (S. aureus) carriage and sensitiza

56 handling and consumption in the transfer of Staphylococcus aureus (S. aureus) from livestock to cons

57 Staphylococcus aureus (S. aureus) infections are among t

58 Colonization of the skin by Staphylococcus aureus (S. aureus) is increased in atopic

59 Staphylococcus aureus (S. aureus) is one of the most com

60 Correspondingly, Staphylococcus aureus (S. aureus) isolates from lesional

61 etection of Lactobacillus species (spp.) and Staphylococcus aureus (S. aureus) using gold nanoparticl

62 wed by Streptococci (Strep) species (20.8%), Staphylococcus aureus (SA) (10.2%), other Gram-positive

63 ife-threatening infectious pathogens such as Staphylococcus aureus (SA) and Mycobacterium tuberculosi

64 lights on the surface of the human pathogens Staphylococcus aureus (SaEf-Tu) and Mycoplasma pneumonia

65 only occurred between siblings suggests that Staphylococcus aureus acquisition in our CF population o

66 ium-dependent antimicrobial activity against Staphylococcus aureus and Bacillus subtilis with MICs ra

67 ainst key Gram-positive pathogens (including Staphylococcus aureus and enterococci), a mode of action

68 hospital acquired infections: gram-positive Staphylococcus aureus and gram-negative Pseudomonas aeru

69 n sequester Ni(II) from two human pathogens, Staphylococcus aureus and Klebsiella pneumoniae, that ut

70 Staphylococcus aureus and P. jirovecii had higher densit

71 nic wounds are typically polymicrobial, with Staphylococcus aureus and Pseudomonas aeruginosa being t

72 Chronic coinfections of Staphylococcus aureus and Pseudomonas aeruginosa frequen

73 strains (Bacillus cereus, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa) and in

74 d be observed for pathogenic bacteria (e.g., Staphylococcus aureus and Pseudomonas aeruginosa).

75 2.6 log reductions of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa, respec

76 t lawn biofilms of bioluminescent strains of Staphylococcus aureus and Pseudomonas aeruginosa.

77 ia Escherichia coli, Listeria monocytogenes, Staphylococcus aureus and Salmonella enteritidis.

78 or-stimulating bacteria in the upper airway (Staphylococcus aureus and Staphylococcus epidermidis) an

79 t Escherichia coli, Mycobacterium smegmatis, Staphylococcus aureus and Staphylococcus simulans.

80 Regarding microorganisms, Staphylococcus aureus and streptococci slightly declined

81 ween CP and two solute-binding proteins that Staphylococcus aureus and Streptococcus pneumoniae, Gram

82 ture had direct bactericidal effects against Staphylococcus aureus and Streptococcus pyogenes and pro

83 ly monitor the growth of both gram-positive (Staphylococcus aureus and Streptococcus pyogenes) and gr

84 oded CRISPR/associated protein 9 (Cas9) from Staphylococcus aureus and Streptococcus pyogenes, and re

85 pecies commonly associated with PJI, namely, Staphylococcus aureus and Streptococcus pyogenes.

86 ning, we employ orthogonal Cas9 enzymes from Staphylococcus aureus and Streptococcus pyogenes.

87 gens (SAgs) are potent exotoxins secreted by Staphylococcus aureus and Streptococcus pyogenes.

88 erial pathogens, including Escherichia coli, Staphylococcus aureus and Vibrio cholera, identified a n

89 loferrin A (SA) and staphyloferrin B (SB) of Staphylococcus aureus are essential for iron acquisition

90 Coagulase-negative staphylococci (CoNS) and Staphylococcus aureus are part of the natural flora of h

91 um of activity of nafithromycin were tested: Staphylococcus aureus ATCC 25923 (disk only), S. aureus

92 Staphylococcus aureus bacteraemia is a common cause of s

93 mulates interleukin 10 (IL-10) production in Staphylococcus aureus bacteremia (SaB) animal models, bu

94 have been shown to improve the management of Staphylococcus aureus bacteremia (SAB).

95 ic infection is an important complication of Staphylococcus aureus bacteremia (SAB).

96 -adhering pathogens, such as Shiga toxin and Staphylococcus aureus bacteria.

97 ine, oxacillin and rifampicin) in preventing Staphylococcus aureus biofilms was investigated using Mi

98 r disparities existed in hospital-onset (HO) Staphylococcus aureus bloodstream infections (BSIs) and

99 fflux pump is involved in internalization of Staphylococcus aureus by A549 lung epithelial cells.

100 Staphylococcus aureus causes very serious infections of

101 The Staphylococcus aureus cell surface contains cell wall-an

102 By contrast, the Gram-positive Staphylococcus aureus cells appeared to be protected fro

103 igate this, we tracked spacer acquisition in Staphylococcus aureus cells harbouring a type II CRISPR-

104 totypic housekeeping sortase A (SaSrtA) from Staphylococcus aureus cleaves LPXTG-containing proteins

105 Livestock-associated methicillin-resistant Staphylococcus aureus clonal complex 398 (LA-MRSA CC398)

106 ed the highest efficiency when P. aeruginosa/Staphylococcus aureus co-culture RNA samples were tested

107 k et al. (2017) find that a commensal blocks Staphylococcus aureus colonization by producing a signal

108 Staphylococcus aureus colonization contributes to skin i

109 Staphylococcus aureus colonization levels inversely corr

110 asal polyps and asthma, show increased nasal Staphylococcus aureus colonization.

111 Staphylococcus aureus commonly colonizes the epidermis,

112 Staphylococcus aureus displays a clonal population struc

113 ted with a low-diversity skin microbiota and Staphylococcus aureus dominance.

114 n and the presence of IgE antibodies against Staphylococcus aureus enterotoxins (SAEs).

115 Staphylococcus aureus expresses a panel of cell wall-anc

116 Staphylococcus aureus forms biofilms on indwelling medic

117 seful single-test adjunct for distinguishing Staphylococcus aureus from S. delphini and other members

118 Staphylococcus aureus from these 2 groups were introduce

119 we observed that IFN-beta can directly kill Staphylococcus aureus Further, a mutant S. aureus that i

120 We investigated de novo mutation in 1163 Staphylococcus aureus genomes from 105 infected patients

121 lular nonsiderophilic Y enterocolitica O8 or Staphylococcus aureus Hepcidin analogs may be useful for

122 Mice with chronic Staphylococcus aureus implant infections were treated by

123 ococcus was isolated in 39 of 63 (62%) eyes, Staphylococcus aureus in 7 of 63 (11%) eyes, and Strepto

124 ve Staphylococci, Pseudomonas aeruginosa and Staphylococcus aureus in keratitis; Streptococcus viridi

125 tyrosine kinase (SYK) activity and uptake of Staphylococcus aureus in microglial cell line BV-2 in a

126 ature myeloid cells, expanded during chronic Staphylococcus aureus infection and promoted bacterial p

127 y to subsequent Streptococcus pneumoniae and Staphylococcus aureus infection as well as the intensity

128 unctionally contribute to protection against Staphylococcus aureus infection.

129 uenza (21 days) did not exacerbate secondary Staphylococcus aureus infection.

130 Clostridium difficile, methicillin-resistant Staphylococcus aureus infections and vancomycin-resistan

131 Multiple candidate vaccines against Staphylococcus aureus infections have failed in clinical

132 Staphylococcus aureus infections of the skin and soft ti

133 cells are the etiologic agents of recurrent Staphylococcus aureus infections.

134 promoted the association and phagocytosis of Staphylococcus aureus into macrophages.

135 Staphylococcus aureus is a highly successful human patho

136 Staphylococcus aureus is a human commensal but also has

137 Staphylococcus aureus is a leading cause of both nosocom

138 Staphylococcus aureus is a major cause of skin and soft

139 The bacterium Staphylococcus aureus is a major human pathogen for whic

140 Staphylococcus aureus is a medically important pathogen

141 The type VII secretion system (T7SS) of Staphylococcus aureus is a multiprotein complex dedicate

142 Staphylococcus aureus is a serious human pathogen with r

143 Staphylococcus aureus is an AD-associated pathogen produ

144 Staphylococcus aureus is an important opportunistic path

145 Staphylococcus aureus is an opportunistic human pathogen

146 Staphylococcus aureus is an opportunistic pathogen and v

147 Skin colonization by Staphylococcus aureus is associated with severity of ato

148 Staphylococcus aureus is highly adapted to its host and

149 Staphylococcus aureus is in competition for colonization

150 Staphylococcus aureus is the leading cause of infection

151 Staphylococcus aureus is the leading cause of skin and s

152 Staphylococcus aureus is the leading cause of skin and s

153 Staphylococcus aureus is the most common cause of skin a

154 Staphylococcus aureus is the most common infectious agen

155 r differentiating S. hyicus, S. agnetis, and Staphylococcus aureus Isolates (n = 62) were selected fr

156 elatedness and assess population dynamics of Staphylococcus aureus isolates from a cohort of CF patie

157 approximately 85% of all relaxases found in Staphylococcus aureus isolates.

158 tect mecC-mediated beta-lactam resistance in Staphylococcus aureus Kriegeskorte and colleagues report

159 Staphylococcus aureus NOS (saNOS) has previously been sh

160 ional structures of ribosomal particles from Staphylococcus aureus obtained by X-ray crystallography

161 lity of phosphate for all forms of life, how Staphylococcus aureus obtains this nutrient during infec

162 onic biofilm-associated infections caused by Staphylococcus aureus often lead to significant increase

163 t of diseases such as tuberculosis, malaria, Staphylococcus aureus or gonorrhea has led to rapidly in

164 It is tougher to treat than most strains of Staphylococcus aureus or staph, because it is resistant

165 t affect phagocytosis of Escherichia coli or Staphylococcus aureus or their intracellular killing.

166 and local epidemiological investigations of Staphylococcus aureus outbreaks.

167 ificant selectivity for PrkA relative to the Staphylococcus aureus PASTA kinase Stk1.

168 Remarkably, the clinically important Staphylococcus aureus pathogenicity islands (SaPIs) use

169 Staphylococcus aureus pathogenicity islands (SaPIs), suc

170 lose sequence relationship between PBP 3 and Staphylococcus aureus PBP 2A, which is responsible for m

171 Staphylococcus aureus plays an important role in sepsis,

172 Antibiotic-resistant strains of Staphylococcus aureus pose a major threat to human healt

173 Airway-colonization by Staphylococcus aureus predisposes to the development of

174 ress response as seen, for example, with the Staphylococcus aureus PRF or sulfide oxidation and dispo

175 2017) define a pathway by which epicutaneous Staphylococcus aureus promotes skin inflammation and may

176 trated that this protease rapidly hydrolyzes Staphylococcus aureus protein A, an important S. aureus

177 To enable high-accuracy quantification of Staphylococcus aureus proteins, we have developed a glob

178 dulin alpha3 (PSMalpha3) peptide secreted by Staphylococcus aureus PSMalpha3 formed elongated fibrils

179 lar microbes, such as the bacterial pathogen Staphylococcus aureus Recruitment and activation of neut

180 do not usually develop effective immunity to Staphylococcus aureus reinfection.

181 Staphylococcus aureus remains a causative agent for morb

182 em into groups, including tandem repeats and Staphylococcus aureus repeat (STAR)-like elements.

183 luate the effect of route of administration, Staphylococcus aureus skin colonization, and disease sev

184 precluded primary outcome meta-analysis for Staphylococcus aureus skin or soft-tissue infections.

185 Here, we describe Staphylococcus aureus sortase A-mediated crosslinking of

186 ed bacteria including a multi-drug resistant Staphylococcus aureus strain Y5 and ampicillin resistant

187 However, superantigen-producing Staphylococcus aureus strains are often part of the huma

188 ma-primed MCs guide activation of T cells by Staphylococcus aureus superantigen and, when preincubate

189 y was to test the ability of WLBU2 to remove Staphylococcus aureus surgical implant biofilms.

190 2-component leukotoxin LukAB is critical for Staphylococcus aureus targeting and killing of human neu

191 Phenotypic variants of Staphylococcus aureus that display small colonies, reduc

192 tor on the surface of the bacterial pathogen Staphylococcus aureus that extracts heme from hemoglobin

193 e followed 3 wk later by an i.v. exposure to Staphylococcus aureus This procedure resulted in a marke

194 d secretion in response to nigericin and the Staphylococcus aureus toxin leukocidin AB (LukAB).

195 ome-wide screen and identified the essential Staphylococcus aureus tRNA m(1)G37 methyltransferase enz

196 Finally, a modular synthesis of the Staphylococcus aureus type 5 capsular polysaccharide rep

197 Small-colony variants (SCVs) of Staphylococcus aureus typically lack a functional electr

198 al. (2017) show that the bacterial pathogen Staphylococcus aureus unexpectedly secretes and repurpos

199 The Gram-positive pathogen Staphylococcus aureus uses one primary resistance mechan

200 The bacterial human pathogen Staphylococcus aureus uses oxygen as a terminal electron

201 activity against Pseudomonas aeruginosa and Staphylococcus aureus was assessed by microdilution assa

202 aused by Escherichia coli, Enterococcus, and Staphylococcus aureus we observed that cocolonization wi

203 Using this method 80.3 +/- 5.6% of Staphylococcus aureus with a starting concentration of

204 ssociation between Clostridium neonatale and Staphylococcus aureus with NEC (P = 0.001 and P = 0.002)

205 L and 95.4 +/- 1.0% of Methicillin-resistant Staphylococcus aureus with starting concentration of 10

206 d short palindromic repeat-associated 9 from Staphylococcus aureus) and guide RNA constructs into an

207 increased susceptibility to both bacterial (Staphylococcus aureus) and viral (murine CMV) infection

208 nella typhimurium, and methicillin-resistant Staphylococcus aureus) were successfully isolated and de

209 tions of those methods, were used to test 10 Staphylococcus aureus, 10 Streptococcus pneumoniae, 10 H

210 rgic reactions to the gram-positive pathogen Staphylococcus aureus, a frequent colonizer of the upper

211 the outcome of systemic infections caused by Staphylococcus aureus, a leading cause of bacterial endo

212 Staphylococcus aureus, a metabolically flexible gram-pos

213 g on NorA, the most important efflux pump of Staphylococcus aureus, an efflux pump inhibitors (EPIs)

214 nk between EET formation and the presence of Staphylococcus aureus, an organism frequently colonizing

215 eir ability to internalize Escherichia coli, Staphylococcus aureus, and Bacillus anthracis particles.

216 ebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, and coagulase-negative staphyloco

217 igh-density populations of Escherichia coli, Staphylococcus aureus, and Mycobacterium smegmatis to qu

218 emophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii.

219 at suppress the growth of a common pathogen, Staphylococcus aureus, and predicted which genera were a

220 y RNAs (sRNA) in P. aeruginosa as well as in Staphylococcus aureus, another important human pathogen

221 monas aeruginosa, Moraxella catarrhalis, and Staphylococcus aureus, bacteria that occasionally coloni

222 ae after challenge with Escherichia coli and Staphylococcus aureus, but had no significant effect aft

223 e been implicated in nosocomial outbreaks of Staphylococcus aureus, but the dearth of evidence from n

224 Gram-negative bacilli, Staphylococcus aureus, Chlamydia, Mycoplasma, and Legion

225 In Staphylococcus aureus, ClpP associates to the substrate

226 As far as this review, Staphylococcus aureus, Coagulase negative Staphylococci,

227 l presence, including the frequent colonizer Staphylococcus aureus, contributes to inhibition of heal

228 t Gram-positive and Gram-negative pathogens (Staphylococcus aureus, Enterobacteriaceae, Pseudomonas a

229 increased uptake in vitro in live bacteria (Staphylococcus aureus, Escherichia coli, and Pseudomonas

230 y in vitro uptake in representative bacteria-Staphylococcus aureus, Escherichia coli, Pseudomonas aer

231 he growth of gram-positive (Bacillus cereus, Staphylococcus aureus, Listeria monocytogenes, Geobacill

232 apid and simultaneous identification (ID) of Staphylococcus aureus, Staphylococcus lugdunensis, and S

233 he world, in the United States for instance, Staphylococcus aureus, Streptococcus pneumoniae and Haem

234 ata sets from six diverse bacterial species: Staphylococcus aureus, Streptococcus pneumoniae, Mycobac

235 However, for Staphylococcus aureus, the accumulation of within-host d

236 In the Gram-positive pathogen Staphylococcus aureus, the membrane-bound ATP-dependent

237 Staphylococcus aureus, the most common pathogen in bone

238 on and infection due to meticillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci,

239 infecting the clinically relevant bacterium Staphylococcus aureus, we demonstrate for the first time

240 By examining secreted virulence factors of Staphylococcus aureus, we determine that the bacterial l

241 decision in the opportunistic human pathogen Staphylococcus aureus, which generates the phenotypic bi

242 Staphylococcus aureus, which has become the predominant

243 ns are a family of potent toxins secreted by Staphylococcus aureus, which target white blood cells pr

244 ed honeys against Pseudomonas aeruginosa and Staphylococcus aureus, with a particular focus on two ma

245 infection, specifically Escherichia coli and Staphylococcus aureus, with differences summarized throu

246 patients presented with significantly lower Staphylococcus aureus-specific serum IgG compared to cys

247 119 targets from Acinetobacter baumannii and Staphylococcus aureus.

248 We probe this strategy using Staphylococcus aureus.

249 nas aeruginosa, Acinetobacter baumannii, and Staphylococcus aureus.

250 lly, naturally and persistently colonised by Staphylococcus aureus.

251 the emergence of antibiotic-resistant (ABR) Staphylococcus aureus.

252 NF) caused by group A Streptococcus (GAS) or Staphylococcus aureus.

253 topic dermatitis are frequently colonized by Staphylococcus aureus.

254 detachment process for the bacterial strain Staphylococcus aureus.

255 ganisms on the in vivo 'essential' genome of Staphylococcus aureus.

256 stic microorganisms such as enteric rods and Staphylococcus aureus.

257 are unable to complement an L27 deletion in Staphylococcus aureus.

258 ciated infections like methicillin-resistant Staphylococcus aureus.

259 PR/Cas9 antimicrobial, broadly applicable to Staphylococcus aureus.

260 nterococcus faecium and meticillin-resistant Staphylococcus aureus.

261 found that spent media from the CoNS species Staphylococcus caprae can inhibit agr-mediated quorum se

262 r pyrrolidonyl arylamidase (PYR) activity in Staphylococcus delphini This study evaluated PYR activit

263 inetobacter and Moraxella species (type II), Staphylococcus epidermidis (type III), Porphyromonas and

264 Staphylococcus epidermidis harbours a Type III-A CRISPR-

265 Staphylococcus epidermidis has emerged as an important o

266 ding clinical isolates of MRSA and MSSA) and Staphylococcus epidermidis identified one candidate that

267 nd show that the common blood-borne pathogen Staphylococcus epidermidis influences this in vitro mode

268 The otherwise harmless skin inhabitant Staphylococcus epidermidis is a major cause of healthcar

269 Staphylococcus epidermidis is one of the primary bacteri

270 Similar proteolytic capacities were found in Staphylococcus epidermidis isolates but not in Staphyloc

271 Here we show that targeting by the Staphylococcus epidermidis type III-A CRISPR-Cas system

272 Staphylococcus epidermidis was used as the model target

273 the upper airway (Staphylococcus aureus and Staphylococcus epidermidis) and intestinal microbiota (L

274 We show that Staphylococcus epidermidis, a commensal bacterium in the

275 Staphylococcus epidermidis, a major component of skin fl

276 d on surfaces, and belong to species such as Staphylococcus epidermidis, Enterococcus faecalis, Pseud

277 The glucose transporter from Staphylococcus epidermidis, GlcPSe, is a homolog of the

278 a significant reduction in viable counts of Staphylococcus epidermidis, Saccharomyces cerevisiae, an

279 by severe sepsis with positive blood culture Staphylococcus haemolyticus, septic shock, multiple orga

280 Staphylococcus hyicus and Staphylococcus agnetis are two

281 us from S. delphini and other members of the Staphylococcus intermedius group.

282 from broth microdilution MIC testing of 993 Staphylococcus lugdunensis isolates recovered from patie

283 dentification (ID) of Staphylococcus aureus, Staphylococcus lugdunensis, and Staphylococcus species t

284 lum, and Corynebacterium, Acinetobacter, and Staphylococcus, often involved in mastitis cases, were t

285 es the B cell response through expression of staphylococcus protein A (SpA), a surface protein that d

286 a dominated by proinflammatory bacteria (eg, Staphylococcus, Pseudomonas, and Corynebacterium), anabo

287 In the absence of Staphylococcus (S.) aureus in NPF, antibiotic therapy as

288 ys, inhibited IFN-beta and in the absence of Staphylococcus (S.) aureus, induced ST2 bearing cells in

289 aphylococcus epidermidis isolates but not in Staphylococcus saprophyticus Galectin-3-induced activati

290 pearance of the multidrug resistant bacteria Staphylococcus simulans in the fetal brain.

291 cterium smegmatis, Staphylococcus aureus and Staphylococcus simulans.

292 A. actinomycetemcomitans and Staphylococcus species do not seem to play an important

293 A total of 658 Staphylococcus species isolates (S. aureus, 211 isolates

294 ccus aureus, Staphylococcus lugdunensis, and Staphylococcus species to the genus level and the detect

295 of Aggregatibacter actinomycetemcomitans and Staphylococcus species was very low.

296 11 isolates; S. lugdunensis, 3 isolates; and Staphylococcus spp., 444 isolates) were recovered from m

297 ram positive bacteria (Enterococcus spp. and Staphylococcus spp., including two MRSA strains 0.3-8 mu

298 Cellulophaga lytica, Bacillus aquimaris and Staphylococcus warneri were undertaken.

299 mmensal isolates such as Microbacterium sp., Staphylococcus warneri, Flectobacillus major, Arthrobact

300 Coagulase-negative Staphylococcus was isolated in 39 of 63 (62%) eyes, Stap